Covered recipient · General Payments record
LINDSEY JOVENE ALDRIDGE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024–2025
$504.82
- Reported across 25 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $370.39 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $168.78 | 7 |
| Lilly USA, LLC | $63.72 | 3 |
| Novo Nordisk AS | $52.67 | 3 |
| Amgen Inc. | $37.43 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $30.55 | 2 |
| GlaxoSmithKline, LLC. | $17.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.86 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204916137 | CMS |
| ABBVIE INC. | $11.41 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204916141 | CMS |
| ABBVIE INC. | $25.33 | 04/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204916145 | CMS |
| ABBVIE INC. | $33.83 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204916150 | CMS |
| ABBVIE INC. | $23.05 | 08/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204916153 | CMS |
| ABBVIE INC. | $34.86 | 09/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204916158 | CMS |
| ABBVIE INC. | $27.44 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204916162 | CMS |
| Aimmune Therapeutics, Inc. | $15.90 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249723943 | CMS |
| Aimmune Therapeutics, Inc. | $14.65 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249723941 | CMS |
| Amgen Inc. | $23.94 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229800215 | CMS |
| Amgen Inc. | $13.49 | 11/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229800224 | CMS |
| GlaxoSmithKline, LLC. | $17.24 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190372086 | CMS |
| Lilly USA, LLC | $21.45 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187217517 | CMS |
| Lilly USA, LLC | $16.27 | 06/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187223509 | CMS |
| Lilly USA, LLC | $26.00 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187177631 | CMS |
| Novo Nordisk Inc | $14.94 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188747929 | CMS |
| Novo Nordisk Inc | $16.49 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188920056 | CMS |
| Novo Nordisk Inc | $21.24 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188965734 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.